Abstract
Sleep apnea is a common disorder associated with obesity and related health problems. Although treatment of sleep apnea may relieve some autonomic symptoms, it is currently unknown whether treatment of sleep apnea is specifically associated with the resolution of orthostatism and syncope. Herein we describe a 73-year-old man who had recurrent episodes of syncope. An extensive work-up, including cardiac and neurologic consultations, failed to identify the cause. An objective sleep evaluation led to the diagnosis of sleep apnea. Accordingly, the patient was treated with continuous positive airway pressure, which resolved the syncopal episodes. This case report generates a potentially important hypothesis that recurrent syncope may be effectively treated, in part, by correcting apnea. In patients with recurrent syncope of unknown etiology, a diagnosis of sleep apnea should be considered.
Sleep apnea refers to disrupted ventilation during sleep and is classified as either obstructive or central.1 Obstructive sleep apnea (OSA) is the most common sleep breathing disorder, discovered more than 4 decades ago and affecting approximately 20% of the population. Prevalence estimates of symptomatic moderate-to-severe OSA range from 0.5% to 4% in the general population.2,3 Symptoms may include loud snoring, witnessed apneas, unrefreshing sleep, daytime somnolence, or impaired cognition. OSA occurs when the upper airways become obstructed because of anatomic factors such as bony abnormalities, soft tissue hypertrophy, and loss of neural reflexes that maintain airway patency during sleep.2,4,5
Autonomic dysfunction is also associated with OSA and may be manifested by decreased heart rate variability, lower baroreflex sensitivity, increased baseline heart rate, and orthostatic hypotension.6,7 Patients with OSA often demonstrate various cardiac dysrhythmias on polysomnography.8 Forty percent of syncope is classified as unexplained.9 However, it is unknown if true syncope is associated with sleep apnea. In addition, resolution of recurrent syncope with treatment of sleep apnea has not been reported.
Case Report
A 73-year-old man with a history of hypertension, esophageal reflux, and a body mass index of 35 complained of episodes of weakness on exertion and at rest. His symptoms gradually worsened during a 10-year period and occurred more frequently when he was exposed to heat and with minimal activity, such as light yard work. Unexplained syncopal episodes progressed to monthly events with concomitant emergency department and primary care physician office evaluations. In addition, the patient reported numerous occasions of collapse and syncope for which he did not seek medical attention. Neurology consultation revealed a possible diagnosis of transient ischemic attack and emergency department physicians diagnosed syncope of unknown etiology. Throughout his course, he noted gradual memory loss. This prompted neuropsychological memory testing, which was normal.
One syncopal event was witnessed by his family physician. The patient was observed to become diaphoretic without pain or dyspnea and then lost consciousness for 2 minutes. No seizure activity was noted. Glucose monitoring and rhythm strips were normal. The patient fully recovered within 3 minutes of regaining consciousness.
Cardiac evaluation included an event recorder, which documented normal sinus rhythm during a presyncopal event. Holter monitor, electrocardiography, stress testing on a treadmill, polysomnography, and ambulatory blood pressure monitoring showed no evidence of conduction disorder, ischemia, or orthostatic fluctuations in blood pressure associated with apneic events. During hospitalization, telemetry and nursing neurology checks revealed nothing. Neurologic evaluations, including magnetic resonance and computed tomographic imaging of the head, were negative. Electroencephalograms during sleep and while awake showed nonspecific patterns, but during the study, the patient fell asleep while seated and snoring was noted. Further questioning of the patient's spouse revealed that the patient had excessive daytime sleepiness.
The patient underwent overnight oximetry and was found to have 292 desaturation events with a minimum oxygen saturation of 73% in a pattern consistent with severe OSA. Polysomnography demonstrated loud snoring and an apnea–hypopnea index (the number of apneic and hypopneic episodes divided by the number of hours of sleep) of 73, with no notable effect of sleeping position on apnea–hypopnea index. Treatment with continuous positive airway pressure (CPAP) nasally abolished snoring and the majority of disordered breathing events.
The patient's nasal CPAP compliance was self-reported at 98%. Although objective confirmation was not available, the patient's wife confirmed his compliance report. Daytime alertness improved dramatically with treatment, and repeat overnight oximetry with treatment was normal. Syncope and near-syncopal events completely resolved without recurrence for 1.5 years since the institution of nasal CPAP therapy.
Discussion
Here we report complete resolution of recurrent syncopal episodes after the diagnosis and treatment of OSA. Before the patient's sleep study he had an extensive work-up, including neurologic and cardiac investigations, that did not identify any known cause for the recurrent syncopal episodes. To our knowledge, this may be the first case that showed complete resolution of recurrent syncope with nasal CPAP treatment. Investigators in Japan reported a patient with OSA who had a marked decrease in the severity of syncope after the institution of nasal CPAP, but they did not observe complete resolution of symptoms.10 This case report generates a potentially important hypothesis that recurrent syncope may be effectively treated, in part, by correcting apnea. In patients with recurrent syncope of unknown etiology, a diagnosis of sleep apnea should be considered. We suggest further study using a larger sample to examine the association between recurrent syncopal episodes of unknown etiology and OSA.
Notes
This article was externally peer reviewed.
Funding: Dr. Geda was supported in part by K01 MH68351 from the National Institutes of Health.
Conflict of interest: none declared.
- Received for publication December 12, 2007.
- Revision received April 8, 2008.
- Accepted for publication April 11, 2008.